cas 4956-05-2|| where to buy 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

Product Name:6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

IUPAC Name:6-bromo-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

Packing Unit	Available Stock	Price($)
CM253184-25g	in stock	ȡƿ
CM253184-100g	in stock	ƃŞȡ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 4956-05-2 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:4956-05-2; Molecular Formula:C3H2BrN3O2; Melting Point:-; Smiles Code:O=C(N1)NN=C(Br)C1=O; Density:

: Catalog Number:CM253184; Molecular Weight:191.97; Boiling Point:; MDL No:MFCD00154757; Storage:Keep in inert atmosphere, store at 2-8°C.

: Triazines; Triazines are an important class of six-membered aromatic heterocycles with three nitrogen atoms that give rise to three regioisomers: 1,2,4-triazines, 1,2,3-triazines, and 1,3, 5-triazine. 1,2,3-Triazines show remarkable reactivity and have attracted attention for their medicinal value. Triazine compounds fused with other carbon and heterocycles are stable and have a broad spectrum of pharmacological activities.

: ALG-055009; Aligos Therapeutics announced positive topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects. ALG-055009 demonstrated a favorable tolerability profile with no serious adverse events (SAEs), or clinical hyper/hypothyroidism. The majority of treatment emergent adverse events (TEAEs) were mild to moderate, with one discontinuation due to worsening insomnia in a subject with pre-existing insomnia.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.